1. Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation
   Zichu Zhao et al, 2016, European Journal of Pharmacology CrossRef
2. Molecular targets of gambogic acid in cancer: recent trends and advancements
   Dharambir Kashyap et al, 2016, Tumor Biology CrossRef
3. Gambogic Acid and Its Role in Chronic Diseases
   Manoj K. Pandey et al, 2016, Anti-inflammatory Nutraceuticals and Chronic Diseases CrossRef
4. An overview of anticancer activity of Garcinia and Hypericum
   Lavínia de C. Brito et al, 2017, Food and Chemical Toxicology CrossRef
5. Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells
   Ling Fu et al, 2018, Oncology Letters CrossRef
6. Therapeutic potential of gambogic acid, a caged xanthone, to target cancer
   Kishore Banik et al, 2018, Cancer Letters CrossRef
7. Design, Synthesis and Anti-cancer Evaluation of Nitrogen-containing Derivatives of 30-Carboxyl of Gambogic Acid
   Hong Li et al, 2024, Anti-Cancer Agents in Medicinal Chemistry CrossRef
8. Role of gambogic acid and NaI131 in A549/DDP cells
   Jing Huang et al, 2017, Oncology Letters CrossRef
9. Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer
   A Elisa Pasqua et al, 2017, Comprehensive Medicinal Chemistry III CrossRef
10. Involvement of E-cadherin/AMPK/mTOR axis in LKB1-induced sensitivity of non-small cell lung cancer to gambogic acid
    Xiaosu Li et al, 2019, Biochemical Pharmacology CrossRef